·        Christian J. I.*, Pastula A.*, Herbst A., Neumann J., Marschall M. K., Ofner A., Zierahn H., Schneider M. R., Wolf E., Quante M., Kolligs F. T. Loss of DRO1/CCDC80 in the tumor microenvironment promotes carcinogenesis.  Oncotarget. 2022; 13: 615-627. 

* co-first authors

 
·       Agnieszka Pastuła#, Richard Lundmark, Induction of epithelial-mesenchymal transition in MDCK II cells. Bio-protocol 11(3), 2021.

·       Pastuła, A. & Marcinkiewicz, J., Cellular Interactions in the Intestinal Stem Cell Niche. Arch. Immunol. Ther. Exp. 2018 Sep 21.

·       Pastuła A, Immunoscore, circulating tumor cells and human-derived organoids as potential predictive tools in personalized cancer medicine. Book chapter. Medical Ethics, Prediction, and Prognosis. Interdisciplinary Perspectives. Chapter 13, pp. 174 - 182. Routledge, 21/04/2017. ISSN 0306-6800.
 
·       Schellnegger R, Quante AS, Rospleszcz S, Schernhammer M, Höhl B, Tobiasch M, Pastula A, Brandtner A, Abrams JA, Strauch K, Schmid RM, Vieth M, Wang TC, Quante M, Goblet-cell ratio in combination with differentiation and stem cell markers in Barrett’s esophagus allow distinction of patients with and without esophageal adenocarcinoma. Cancer Prevention Research. 2016 Nov 2.
 
·       Pastula A, Middelhoff M, Brandtner A, Tobiasch M, Höhl B, Nuber AH, Demir E, Neupert S, Kollmann P, Mazzuoli-Weber G, Quante M, Three dimensional intestinal crypt culture in combination with nerves or fibroblasts – a method to characterize the gastrointestinal stem cell niche. Stem Cells Int. 2016.
 
·       Boross P, Jansen JH, Pastula A, van der Poel CE, Leusen JH. Both activating and inhibitory Fc gamma receptors mediate rituximab-induced trogocytosis of CD20 in mice. Immunol Lett. 2012.
 
·       Pastuła A#, Marcinkiewicz J. Myeloid-derived suppressor cells: a double-edged sword? Int J Exp Pathol. 2011.

# corresponding author

Google Scholar: https://scholar.google.com/citations?user=9iAOGQ4AAAAJ&hl=pl&oi=ao